Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1984 1
1985 1
1986 4
1987 1
1990 1
1991 4
1992 2
1993 5
1994 1
1995 4
1996 1
1997 3
1998 1
1999 1
2000 2
2001 3
2002 4
2003 5
2004 6
2005 4
2006 5
2007 5
2008 3
2009 7
2010 11
2011 9
2012 9
2013 12
2014 10
2015 7
2016 6
2017 8
2018 6
2019 9
2020 13
2021 10
2022 5
2023 8
2024 10
2025 11
2026 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

190 results

Results by year

Filters applied: . Clear all
Page 1
Consensus on the treatment of dysphagia in Parkinson's disease.
Schindler A, Pizzorni N, Cereda E, Cosentino G, Avenali M, Montomoli C, Abbruzzese G, Antonini A, Barbiera F, Benazzo M, Benarroch E, Bertino G, Clavè P, Cortelli P, Eleopra R, Ferrari C, Hamdy S, Huckabee ML, Lopiano L, Marchese-Ragona R, Masiero S, Michou E, Occhini A, Pacchetti C, Pfeiffer RF, Restivo DA, Rondanelli M, Ruoppolo G, Sandrini G, Schapira A, Stocchi F, Tolosa E, Valentino F, Zamboni M, Zangaglia R, Zappia M, Tassorelli C, Alfonsi E. Schindler A, et al. Among authors: pacchetti c. J Neurol Sci. 2021 Nov 15;430:120008. doi: 10.1016/j.jns.2021.120008. Epub 2021 Sep 27. J Neurol Sci. 2021. PMID: 34624796 Free article.
A multinational consensus on dysphagia in Parkinson's disease: screening, diagnosis and prognostic value.
Cosentino G, Avenali M, Schindler A, Pizzorni N, Montomoli C, Abbruzzese G, Antonini A, Barbiera F, Benazzo M, Benarroch EE, Bertino G, Cereda E, Clavè P, Cortelli P, Eleopra R, Ferrari C, Hamdy S, Huckabee ML, Lopiano L, Marchese Ragona R, Masiero S, Michou E, Occhini A, Pacchetti C, Pfeiffer RF, Restivo DA, Rondanelli M, Ruoppolo G, Sandrini G, Schapira AHV, Stocchi F, Tolosa E, Valentino F, Zamboni M, Zangaglia R, Zappia M, Tassorelli C, Alfonsi E. Cosentino G, et al. Among authors: pacchetti c. J Neurol. 2022 Mar;269(3):1335-1352. doi: 10.1007/s00415-021-10739-8. Epub 2021 Aug 21. J Neurol. 2022. PMID: 34417870 Free PMC article. Review.
Safety and efficacy of continuous subcutaneous levodopa-carbidopa infusion (ND0612) for Parkinson's disease with motor fluctuations (BouNDless): a phase 3, randomised, double-blind, double-dummy, multicentre trial.
Espay AJ, Stocchi F, Pahwa R, Albanese A, Ellenbogen A, Ferreira JJ, Giladi N, Gurevich T, Hassin-Baer S, Hernandez-Vara J, Isaacson SH, Kieburtz K, LeWitt PA, Lopez-Manzanares L, Olanow CW, Poewe W, Sarva H, Yardeni T, Adar L, Salin L, Lopes N, Sasson N, Case R, Rascol O; BouNDless Study Group. Espay AJ, et al. Lancet Neurol. 2024 May;23(5):465-476. doi: 10.1016/S1474-4422(24)00052-8. Epub 2024 Mar 15. Lancet Neurol. 2024. PMID: 38499015 Clinical Trial.
Safety and efficacy of venglustat in GBA1-associated Parkinson's disease: an international, multicentre, double-blind, randomised, placebo-controlled, phase 2 trial.
Giladi N, Alcalay RN, Cutter G, Gasser T, Gurevich T, Höglinger GU, Marek K, Pacchetti C, Schapira AHV, Scherzer CR, Simuni T, Minini P, Sardi SP, Peterschmitt MJ. Giladi N, et al. Among authors: pacchetti c. Lancet Neurol. 2023 Aug;22(8):661-671. doi: 10.1016/S1474-4422(23)00205-3. Lancet Neurol. 2023. PMID: 37479372 Clinical Trial.
Unraveling the role of GBA1 genotype in axial signs response to subthalamic deep brain stimulation.
Bove F, Genovese D, De Biase A, Albanese A, Antonini A, Artusi CA, Avanzino L, Avenali M, Baldelli L, Calandra-Buonaura G, Cani I, Casasoli N, Cavallieri F, Cilia R, Cocco A, Colucci F, Di Biasio F, D'Onofrio V, Eleopra R, Fioravanti V, Giannini G, Golfre' Andreasi N, Guerra A, Imbalzano G, Izzo A, Ledda C, Liccari M, Lopiano L, Malaguti MC, Minardi R, Mitrotti P, Romito LM, Valente EM, Valzania F, Zangaglia R, Calabresi P, Piano C, Bentivoglio AR; Italian PARKNET Study. Bove F, et al. NPJ Parkinsons Dis. 2025 Oct 17;11(1):296. doi: 10.1038/s41531-025-01140-7. NPJ Parkinsons Dis. 2025. PMID: 41107307 Free PMC article.
Parkinsonism and cerebrospinal fluid disorders.
Youn J, Todisco M, Zappia M, Pacchetti C, Fasano A. Youn J, et al. Among authors: pacchetti c. J Neurol Sci. 2022 Feb 15;433:120019. doi: 10.1016/j.jns.2021.120019. Epub 2021 Oct 1. J Neurol Sci. 2022. PMID: 34674853 Review.
Effects of GBA1 Variants in Patients With Parkinson's Disease and Levodopa-Carbidopa Intestinal Gel: A Nation-Wide, Multicenter, Longitudinal, "Real-World" Study. The EPIC Study.
Cilia R, Colucci F, Cereda E, Elia AE, Leta V, Barca S, Zibetti M, Carecchio M, Bonvegna S, Calandra-Buonaura G, Cerroni R, De Micco R, Tamburin S, Magistrelli L, Lena F, Mascia MM, Picillo M, Cossu G, Marano M, Zampogna A, Pellicano C, Fioravanti V, Pilotto A, Zangaglia R, Avenali M, Sorbera C, Di Biasio F, Arienti F, Nicoletti A, Bagella C, Malaguti MC, Ranghetti A, Caputo E, Alimonti D, Torre E, Oggioni GD, Leuzzi C, Romito LM, Andreasi NG, Devigili G, Telese R, Braccia A, Gaudiano G, Mazzetti S, Invernizzi F, Garavaglia B, Imbalzano G, Ledda C, Antenucci P, Gozzi A, Bonato G, Percetti M, Giannini G, Sambati L, Schirinzi T, D'Anna M, Rinaldi D, Cavallieri F, Liccari M, Priori A, Sessa M, Tamma F, Canesi M, Solla P, Zappia M, Di Fonzo A, Avanzino L, Quartarone A, Valente EM, Pacchetti C, Padovani A, Valzania F, Pontieri FE, Suppa A, Pellecchia MT, Modugno N, Comi C, Tinazzi M, Tessitore A, Stefani A, Cortelli P, Isaias IU, Antonini A, Sensi M, Lopiano L, Eleopra R. Cilia R, et al. Among authors: pacchetti c. Eur J Neurol. 2025 Jul;32(7):e70179. doi: 10.1111/ene.70179. Eur J Neurol. 2025. PMID: 40662275 Free PMC article.
Long-Term Motor and Cognitive Outcome of Deep Brain Stimulation in Patients With Parkinson Disease With a GBA1 Pathogenic Variant.
Avenali M, Artusi CA, Cilia R, Giannini G, Cuconato G, Albanese A, Golfrè Andreasi N, Antenucci P, Antonini A, Avanzino L, Baldelli L, Bentivoglio AR, Bove F, Bozzali M, Calandra-Buonaura G, Cani I, Carelli V, Cavallieri F, Cocco A, Cogiamanian F, Colucci F, Cortelli P, De Biase A, Di Biasio F, Di Fonzo A, D'Onofrio V, Eleopra R, Elia AE, Fioravanti V, Genovese D, Guerra A, Imarisio A, Ledda C, Liccari M, Longo C, Lopiano L, Malaguti MC, Malito R, Mameli F, Marino S, Minardi R, Mitrotti P, Monfrini E, Pacchetti C, Piano C, Rispoli V, Rizzone MG, Romito LM, Sambati L, Sensi M, Sorbera C, Spagnolo F, Tassorelli C, Valentino F, Valzania F, Zangaglia R, Zibetti M; Italian PARKNET Study Group; Valente EM. Avenali M, et al. Among authors: pacchetti c. Neurology. 2025 Nov 11;105(9):e214036. doi: 10.1212/WNL.0000000000214036. Epub 2025 Oct 22. Neurology. 2025. PMID: 41124650 Free PMC article.
Are patients with GBA-Parkinson disease good candidates for deep brain stimulation? A longitudinal multicentric study on a large Italian cohort.
Avenali M, Zangaglia R, Cuconato G, Palmieri I, Albanese A, Artusi CA, Bozzali M, Calandra-Buonaura G, Cavallieri F, Cilia R, Cocco A, Cogiamanian F, Colucci F, Cortelli P, Di Fonzo A, Eleopra R, Giannini G, Imarisio A, Imbalzano G, Ledda C, Lopiano L, Malaguti MC, Mameli F, Minardi R, Mitrotti P, Monfrini E, Spagnolo F, Tassorelli C, Valentino F, Valzania F, Pacchetti C, Valente EM; PARKNET Study Group. Avenali M, et al. Among authors: pacchetti c. J Neurol Neurosurg Psychiatry. 2024 Mar 13;95(4):309-315. doi: 10.1136/jnnp-2023-332387. J Neurol Neurosurg Psychiatry. 2024. PMID: 37879897 Free PMC article.
190 results